Former president of Mexico, Vicente Fox Quesada, was featured on a CNBC segment of Squawk Box. In the interview, Fox discussed the new trade deal between Mexico, the US and Canada, the border dispute between his country and its northern neighbor and the growing cannabis industry.
In addressing the cannabis industry, Fox suggested that the cannabis industry is facing increasing growth across Latin America. “The wave is expanding, the investment is flowing, and the growth is forecasted very high,” he said. He spoke to the upcoming legalization in Mexico, which is expected to open both the medical and recreational markets within the next few months.
He also proffered his view on how the US might benefit from legalizing cannabis at the federal level, suggesting that the country would benefit from returns on investment, as seen in Colombia and Canada.
Fox is also playing a role in the industry as a director to Khiron Life Sciences Corp. (TSXV:KHRN), a vertically-integrated cannabis company developing operations in Colombia, Mexico, and other markets in the Latin American region. In speaking about the company, he discussed how it is focused on the medical industry, developing products and systems that can address the patient. The company is investing funds into research and development in the space.
To watch the full interview, click here.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).